Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells
|
Mar 2015
|
Nat Biotechnol
|
myelodysplastic syndromes (MDS)
|
Front-line immunosuppressive treatment of acquired aplastic anemia
|
Nov 2012
|
Bone Marrow Transplant
|
aplastic anemia
|
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria
|
Mar 2021
|
Blood cells, molecules and diseases
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria
|
Dec 2020
|
Blood, cells, molecules & diseases
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Following in the footsteps of acute myeloid leukemia: are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes?
|
Oct 2020
|
Leukemia & Lymphoma
|
myelodysplastic syndromes (MDS)
|
Following in the footsteps of acute myeloid leukemia: are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes?
|
Oct 2020
|
Leukemia & Lymphoma
|
myelodysplastic syndromes (MDS)
|
Focal Adhesion Kinase as a Potential Target in AML and MDS
|
Mar 2017
|
Mol Cancer Ther
|
myelodysplastic syndromes (MDS)
|
Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels
|
Apr 2012
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
Flow cytometry to distinguish myelodysplastic syndromes from non-neoplastic causes of cytopenia: Ready for prime time?
|
Jun 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
|
Jun 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|